Abstract
The diagnosis of infective endocarditis (IE) must be made as soon as possible to initiate antimicrobial therapy and identify patients at high risk for complications who may be best managed by early surgery. Cerebral complications make the timing of cardiac surgery difficult. The safety of cardiopulmonary bypass (CPB) surgery in stroke patients remains controversial. Stroke complicates the outcome of left-sided IE in 20–40% of cases and is associated with poor outcome. The risk of stroke in IE falls rapidly after the initiation of effective antimicrobial therapy. The risk of embolization is highest during the first week of therapy, and in patients with mobile vegetations or vegetations >10 mm in diameter occurring on the anterior mitral leaflet. Indications for valvular surgery are significant congestive heart failure or valvular regurgitation, myocardial abscess, persistent bacteremia and large-size vegetations with high risk of embolism. Decisions regarding surgical intervention in patients with IE should be individualized. In the absence of large prospective studies, optimal timing of surgery is still discussed when stroke complicates IE. A multidisciplinary assessment of the situation, involving cardiologists, cardiac surgeons, infectiologists and neurologists, is recommended. Estimating the risk of recurrence after a first embolic event and careful evaluation of the indication for valve replacement are essential steps in making the therapeutic decision. Surgery should be delayed if possible in the event of large cerebral infarction or ICH in order to prevent neurological deterioration. It has been suggested that valve replacement should be considered within the first 72 h if the patients with brain infarction have severe heart failure, otherwise after 4 weeks. Early surgery appears safe in patients presenting transient ischemic attacks or “silent” cerebral embolism.
Similar content being viewed by others
References
Netzer RO, Zollinger E, Seiler C, Cerny A (2000) Infective endocarditis: clinical spectrum, presentation and outcome: an analysis of 212 cases 1980–1995. Heart 84:25–30
Mylonakis E, Calderwood SB (2001) Infective endocarditis in adults. N Engl J Med 345:1318–1330
Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81
Beynon RP, Bahl VK, Prendergast BD (2006) Infective endocarditis. Br Med J 333:334–339
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169:463–473
Salgado AV, Furlan AJ, Keys TF, Nickols TR, Beck GJ (1989) Neurologic complications of endocarditis: a 12-year experience. Neurology 39:173–178
Hart RG, Foster JW, Luther MF, Kanter MC (1990) Stroke in infective endocarditis. Stroke 21:695–700
Kanter MC, Hart RG (1991) Neurologic complications of infective endocarditis. Neurology 41:1015–1020
Horstkotte D, Follath F, Gutschik E, Lengvel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P, Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis: the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276
Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A, Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G (2007) Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 28:1155–1161
Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, Olaison L (2008) Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47:23–30
Subramaniam S, Puetz V, Dzialowski I, Barber BA (2006) Cerebral microhemorrhages in a patient with mycotic aneurysm: relevance of T2-GRE imaging in SBE. Neurology 67:1697
Klein I, Iung B, Wolff M, Brochet E, Longuet P, Laissy JP, Duval X (2007) Silent T2* cerebral microbleeds: a potential new imaging clue in infective endocarditis. Neurology 68:2043
Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Green PS (1996) Valve replacement in patients with endocarditis and neurologic deficit. Ann Thorac Surg 61:1125–1130
Piper C, Wiemer M, Schulte HD, Horstkotte D (2001) Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 10:703–711
Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:394–434
Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P (2000) Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 160:2781–2787
Mugge A, Daniel WG, Frank G, Lichtlen PR (1989) Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 14:631–638
Rohmann S, Erbel R, Görge G, Makowski T, Mohr-Kahaly S, Nixdorff U, Drexler M, Meyer J (1992) Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J 12:446–452
Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R (2001) Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37:1069–1076
Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C, Mancini L, Sanz O, Sanmartin JV, Stoermann W (2002) Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 39:1489–1495
Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP, Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabro R, Riberi A, Collart F, Metras D, Lepidi H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G (2005) Risk of embolism and death in infective endocarditis: prognostic value of echocardiography. A prospective multicenter study. Circulation 112:69–75
Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Guiliani ER, Wilson WR (1991) Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 114:635–640
Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, Doco-Lecompte T, Eisen DP, Fortes CQ, Fowler VG Jr, Lerakis S, Miro JM, Pappas P, Peterson GE, Rubinstein E, Sexton DJ, Suter F, Tornos P, Verhagen DW, Cabell CH, ICE Investigators (2007) The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 154:1086–1094
Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, Sexton DJ (2003) Stroke location, characterization, severity, and outcome in mitral versus aortic valve endocarditis. Neurology 61:1341–1346
Sanfilippo AJ, Picard MH, Newell JB, Rosas E, Davidoff R, Thomas JD, Weyman AE (1991) Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 18:1191–1199
Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, Oelert H, Meyer J (1988) Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal: a prospective study. Eur Heart J 9:43–53
Pergola V, Di Salvo G, Habib G, Avierinos JF, Philip E, Vailloud JM, Thuny F, Casalta JP, Ambrosi P, Lambert M, Riberi A, Ferracci A, Mesana T, Metras D, Harle JR, Weiller PJ, Raoult D, Luccioni R (2001) Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol 88:871–875
Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H (1999) The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 33:1365–1371
Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC (2006) Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 37:2094–2099
Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T (1995) Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 110:1745–1755
Angstwurm K, Borges AC, Halle E, Schielke E, Einhäupl KM, Weber JR (2004) Timing the valve replacement in infective endocarditis involving the brain. J Neurol 251:1220–1226
Peters PJ, Harrison T, Lennox JL (2006) A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 6:742–748
Bingham WF (1977) Treatment of mycotic intracranial aneurysms. J Neurosurg 46:428–437
Ahmadi J, Tung H, Giannotta SL, Destian S (1993) Monitoring of infectious intracranial aneurysms by sequential computed tomographic/magnetic resonance imaging studies. Neurosurgery 32:45–49
Corr P, Wright M, Handler LC (1995) Endocarditis-related cerebral aneurysms: radiologic changes with treatment. Am J Neuroradiol 16:745–748
Bohmfalk GL, Story JL, Wissinger JP, Brown WE Jr (1978) Bacterial intracranial aneurysm. J Neurosurg 48:369–382
Wilson WR, Giuliani ER, Danielson GK, Geraci JE (1982) Management of complications of infective endocarditis. Mayo Clin Proc 57:162–170
Moskowitz MA, Rosenbaum AE, Tyler HR (1974) Angiographically monitored resolution of cerebral mycotic aneurysms. Neurology 24:1103–1108
Chapot R, Houdart E, Saint-Maurice JP, Aymard A, Mounayer C, Lot G, Merland JJ (2002) Endovascular treatment of cerebral mycotic aneurysms. Radiology 222:389–396
Chun JY, Smith W, Halbach VV, Higashida RT, Wilson CB, Lawton MT (2001) Current multimodality management of infectious intracranial aneurysms. Neurosurgery 48:1203–1213
Asai T, Usui A, Miyachi S, Ueda Y (2002) Endovascular treatment for intracranial mycotic aneurysms prior to cardiac surgery. Eur J Cardiothorac Surg 21:948–950
Acknowledgment
The authors would like to thank Miss Frédérique Groga-Bada for her help in the preparation of this manuscript.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Derex, L., Bonnefoy, E. & Delahaye, F. Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol 257, 315–321 (2010). https://doi.org/10.1007/s00415-009-5364-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5364-3